48 results
8-K
TVTX
Travere Therapeutics Inc
4 Dec 23
Cost Associated with Exit or Disposal Activities
4:10pm
quarter of 2024.
As part of the Strategic Reorganization, the Company is implementing an approximate 20% workforce reduction focused on non-field … . The Company expects that the majority of the restructuring charges will be incurred in Q4 2023 and that the implementation of the workforce reduction
8-K
EX-99.1
flojs
13 May 19
Departure of Directors or Certain Officers
4:42pm
8-K
EX-99.1
e7u0gj5
19 May 20
Departure of Directors or Certain Officers
4:12pm